Showing results (1091-1100 of 1,541) with videos related to
Sort By:
Pageof 155
Biophysical Chemistry|June 14, 2019
A simple linearization method unveils hidden enzymatic assay interferencesMaria Filipa Pinto, Jorge Ripoll-Rozada, Helena Ramos, et al.Thyroid : Official Journal of the American Thyroid Association|April 4, 2020
The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Health Care SettingTanya Chen, Brian M Gilfix, Juan Rivera, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Structure-guided engineering of tick evasins for targeting chemokines in inflammatory diseasesRam Prasad Bhusal, Pramod Aryal, Shankar Raj Devkota, et al.The Biochemical Journal|March 18, 2011
Structural investigation of inhibitor designs targeting 3-dehydroquinate dehydratase from the shikimate pathway of Mycobacterium tuberculosisMarcio V B Dias, William C Snee, Karen M Bromfield, et al.Human Genetics|October 19, 2011
Large-scale genome-wide association study of Asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependenceDankyu Yoon, Young-Jin Kim, Wen-Yan Cui, et al.Journal of Medical Genetics|February 1, 1996
A genetic register for von Hippel-Lindau diseaseI R Maddock, A Moran, E R Maher, et al.ACS Applied Materials & Interfaces|July 24, 2020
Exsolution of Catalytically Active Iridium Nanoparticles from Strontium TitanateEleonora Calì, Gwilherm Kerherve, Faris Naufal, et al.Structure (London, England : 1993)|February 27, 2026
Discovery of an evolutionarily distinct evasin with dual CC and CXC chemokine inhibitory activitySurendra Kunwar, Shankar Raj Devkota, Caroline Ang, et al.British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 29, 2011
Towards new business models for R&D for novel antibioticsA D So, N Gupta, S K Brahmachari, et al.Pageof 155